scholarly article | Q13442814 |
P2093 | author name string | Timothy J Lacy | |
Charles D Motsinger | |||
Gregory A Perron | |||
P433 | issue | 11 | |
P921 | main subject | dementia | Q83030 |
P304 | page(s) | 2335-2340 | |
P577 | publication date | 2003-06-01 | |
P1433 | published in | American Family Physician | Q4743731 |
P1476 | title | Use of atypical antipsychotic drugs in patients with dementia | |
P478 | volume | 67 |
Q43788567 | A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease |
Q38015698 | Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia? |
Q42622024 | Long-term effects of rivastigmine treatment on the need for psychotropic medications in nursing home patients with Alzheimer's disease : results of a 52-week open-label study |
Q46421706 | Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: risks of cerebrovascular events. A controlled, open-label study. |
Q42133419 | Psychotic symptoms in the elderly |
Q50885299 | Senile Dementia from Neuroscientific and Islamic Perspectives. |
Q96303202 | The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use |
Search more.